《大行報告》匯豐研究升同程藝龍(00780.HK)評級至「買入」 目標價上調至21元
匯豐研究發表報告,將同程藝龍(00780.HK)今明年度的盈利預期分別提高了5%和10%,因收入和利潤率預期提高。目標價由15元上調至21元,意味著16.7%的上升空間。由於利潤率的恢復快過預期,以及國內旅遊市場的快速復甦,將評級由「持有」升至「買入」。
匯豐研究預計,同程藝龍今年第二季將較2019年加速增長,因為國內旅遊市場快速復甦,例如五一勞動節假期期間遊客總數超過2019年水平3%;4月航空或火車票量回升至2019年水平的96%及92%,以及公司戰略性地將營銷費用投入到品牌、活動和用戶獲取渠道以捕捉需求。根據公司指引,今年第二季淨收入與2019年相比將增長30%至35%,非通用會計準則純利介乎3.5億至4億元人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.